Patient-Specific Metrics of Invasiveness Reveal Significant Prognostic Benefit of Resection in a Predictable Subset of Gliomas
暂无分享,去创建一个
Kristin R. Swanson | Guy M. McKhann | Albert Lai | Peter Canoll | Jeffrey N. Bruce | Andrew D. Trister | Kamala Clark-Swanson | Robert C. Rostomily | David Corwin | Sandra Johnston | Sunyoung Ahn | Russell Rockne | Daniel L. Silbergeld | G. Mckhann | T. Cloughesy | D. Silbergeld | P. Canoll | K. Swanson | R. Rostomily | A. Trister | J. Bruce | M. Mrugala | R. Rockne | A. Lai | A. Sonabend | M. Neal | H. Malone | Timothy Cloughesy | Anne L. Baldock | Maxwell Neal | Greg Sterin | Hani Malone | Victoria Ebiana | Adam M. Sonabend | Maciej Mrugala | Jason K. Rockhill | Sunyoung Ahn | A. Baldock | J. Rockhill | S. Johnston | K. Clark-Swanson | V. Ebiana | D. Corwin | Greg Sterin
[1] E. Kasper,et al. Extent of resection and radiotherapy in GBM: A 1973 to 2007 surveillance, epidemiology and end results analysis of 21,783 patients. , 2013, International journal of oncology.
[2] Michael Buchfelder,et al. Surgical resection of malignant gliomas—role in optimizing patient outcome , 2013, Nature Reviews Neurology.
[3] Kristin R. Swanson,et al. Discriminating Survival Outcomes in Patients with Glioblastoma Using a Simulation-Based, Patient-Specific Response Metric , 2013, PloS one.
[4] H. Kishima,et al. 11C‐methionine uptake and intraoperative 5‐aminolevulinic acid‐induced fluorescence as separate index markers of cell density in glioma , 2012, Cancer.
[5] Patrick Y Wen,et al. Application of Novel Response/Progression Measures for Surgically Delivered Therapies for Gliomas: Response Assessment in Neuro-Oncology (RANO) Working Group , 2012, Neurosurgery.
[6] Paul E Kinahan,et al. Applying a patient-specific bio-mathematical model of glioma growth to develop virtual [18F]-FMISO-PET images. , 2011, Mathematical medicine and biology : a journal of the IMA.
[7] Volker Seifert,et al. Intraoperative MRI guidance and extent of resection in glioma surgery: a randomised, controlled trial. , 2011, The Lancet. Oncology.
[8] Pieter L Kubben,et al. Intraoperative MRI-guided resection of glioblastoma multiforme: a systematic review. , 2011, The Lancet. Oncology.
[9] Mitchel S Berger,et al. An extent of resection threshold for newly diagnosed glioblastomas. , 2011, Journal of neurosurgery.
[10] Walter Stummer,et al. Cytoreductive surgery of glioblastoma as the key to successful adjuvant therapies: new arguments in an old discussion , 2011, Acta Neurochirurgica.
[11] Jörg-Christian Tonn,et al. Counterbalancing risks and gains from extended resections in malignant glioma surgery: a supplemental analysis from the randomized 5-aminolevulinic acid glioma resection study. Clinical article. , 2011, Journal of neurosurgery.
[12] Xiaoyao Fan,et al. Coregistered fluorescence-enhanced tumor resection of malignant glioma: relationships between δ-aminolevulinic acid-induced protoporphyrin IX fluorescence, magnetic resonance imaging enhancement, and neuropathological parameters. Clinical article. , 2011, Journal of neurosurgery.
[13] P. Black,et al. Scale to predict survival after surgery for recurrent glioblastoma multiforme. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] P. Kelly. Imaging features of invasion and preoperative and postoperative tumor burden in previously untreated glioblastoma: Correlation with survival , 2010, Surgical neurology international.
[15] K Hendrickson,et al. Predicting the efficacy of radiotherapy in individual glioblastoma patients in vivo: a mathematical modeling approach , 2010, Physics in medicine and biology.
[16] Albert Lai,et al. Prognostic significance of growth kinetics in newly diagnosed glioblastomas revealed by combining serial imaging with a novel biomathematical model. , 2009, Cancer research.
[17] Alfredo Quinones-Hinojosa,et al. ASSOCIATION OF SURGICALLY ACQUIRED MOTOR AND LANGUAGE DEFICITS ON OVERALL SURVIVAL AFTER RESECTION OF GLIOBLASTOMA MULTIFORME , 2009, Neurosurgery.
[18] Gargi Chakraborty,et al. Quantitative metrics of net proliferation and invasion link biological aggressiveness assessed by MRI with hypoxia assessed by FMISO-PET in newly diagnosed glioblastomas. , 2009, Cancer research.
[19] J M Wardlaw,et al. Velocity of radial expansion of contrast-enhancing gliomas and the effectiveness of radiotherapy in individual patients: a proof of principle. , 2008, Clinical oncology (Royal College of Radiologists (Great Britain)).
[20] Kristin R. Swanson,et al. Quantifying glioma cell growth and invasion in vitro , 2008, Math. Comput. Model..
[21] K. Swanson,et al. A mathematical modelling tool for predicting survival of individual patients following resection of glioblastoma: a proof of principle , 2007, British Journal of Cancer.
[22] Kristin R. Swanson,et al. The Evolution of Mathematical Modeling of Glioma Proliferation and Invasion , 2007, Journal of neuropathology and experimental neurology.
[23] Michael E. Berens,et al. Molecular Mechanisms of Glioma Cell Migration and Invasion , 2004, Journal of Neuro-Oncology.
[24] J. Murray,et al. Virtual and real brain tumors: using mathematical modeling to quantify glioma growth and invasion , 2003, Journal of the Neurological Sciences.
[25] Z L Gokaslan,et al. A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. , 2001, Journal of neurosurgery.
[26] J. Murray,et al. A quantitative model for differential motility of gliomas in grey and white matter , 2000, Cell proliferation.
[27] K. Welvaart. The Extent of the Resection , 1980 .
[28] L. J. Karnosh,et al. Residual function following hemispherectomy for tumour and for infantile hemiplegia. , 1955, Brain : a journal of neurology.